Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

13 Résultats de recherche.
Pertinence Commentaire Plus récent Moins récent

Vital Signs and Physical Examination 6- Weeks Visits SirTac NCT02936388 - Vital Signs and Physical Examination 6- Weeks Visits

- 03/12/2017 - 1 Formulaire, 2 Groupes Item, 31 Eléments de données, 1 Langue
Groupes Item: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination 6- Weeks Visits. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination 12- Weeks Visits SirTac NCT02936388 - Vital Signs and Physical Examination 12- Weeks Visits

- 03/12/2017 - 1 Formulaire, 2 Groupes Item, 31 Eléments de données, 1 Langue
Groupes Item: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination 12- Weeks Visits. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination 3- Weeks Visits SirTac NCT02936388 - Vital Signs and Physical Examination 3- Weeks Visits

- 03/12/2017 - 1 Formulaire, 2 Groupes Item, 31 Eléments de données, 1 Langue
Groupes Item: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination 3- Weeks Visits. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination End of Therapy SirTac NCT02936388 - Vital Signs and Physical Examination End of Therapy

- 28/11/2017 - 1 Formulaire, 2 Groupes Item, 31 Eléments de données, 1 Langue
Groupes Item: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination End of Therapy. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Medical History Visit 08 SirTac NCT02936388 - Medical History Visit 08

- 26/11/2017 - 1 Formulaire, 2 Groupes Item, 11 Eléments de données, 1 Langue
Groupes Item: Visit, quality of life
Study part: Medical History Visit 08. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination Visit 07 SirTac NCT02936388 - Vital Signs and Physical Examination Visit 07

- 26/11/2017 - 1 Formulaire, 2 Groupes Item, 31 Eléments de données, 1 Langue
Groupes Item: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination Visit 07. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination Visit 06 SirTac NCT02936388 - Vital Signs and Physical Examination Visit 06

- 26/11/2017 - 1 Formulaire, 2 Groupes Item, 31 Eléments de données, 1 Langue
Groupes Item: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination Visit 06. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination Visit 03 SirTac NCT02936388 - Vital Signs and Physical Examination Visit 03

- 26/11/2017 - 1 Formulaire, 2 Groupes Item, 31 Eléments de données, 1 Langue
Groupes Item: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination Visit 03. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination Before every SIRT- or TACE- Treatment SirTac NCT02936388 - Vital Signs and Physical Examination Before every SIRT- or TACE- Treatment

- 26/11/2017 - 1 Formulaire, 2 Groupes Item, 31 Eléments de données, 1 Langue
Groupes Item: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination Before every SIRT- or TACE- Treatment. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination Screening Day -14 to 0 SirTac NCT02936388 - Vital Signs and Physical Examination Screening Day -14 to 0

- 26/11/2017 - 1 Formulaire, 2 Groupes Item, 33 Eléments de données, 1 Langue
Groupes Item: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination Screening Day -14 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and ECOG Screening Day -7 to 0 SirTac NCT02936388 - Vital Signs and ECOG Screening Day -7 to 0

- 26/11/2017 - 1 Formulaire, 2 Groupes Item, 18 Eléments de données, 1 Langue
Groupes Item: vital signs, quality of life
Study part: Vital Signs and ECOG Screening Day -7 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and ECOG Screening Day -7 to 0 SirTac NCT02936388 - Vital Signs and ECOG Screening Day -7 to 0

- 20/11/2017 - 1 Formulaire, 2 Groupes Item, 18 Eléments de données, 1 Langue
Groupes Item: vital signs, quality of life
Study part: Vital Signs and ECOG Screening Day -7 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial